AN UNBIASED VIEW OF TOFACITINIB

Correct studies done to this point have not shown pediatric-certain challenges that might Restrict the usefulness of tofacitinib tablet and oral liquid in youngsters two to 17 yrs of age with pcJIA. Protection and efficacy are proven.Explain to your physician or nurse For those who have head aches, nosebleeds, blurred or double vision or shortness